Safety of BK1301 in healthy adults

Status

Unknown

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080222663

Enrollment

Registered

2014-11-21

Start date

2014-11-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diphtheria, Tetanus, Pertussis prevention

Interventions

investigational material(s) Generic name etc : BK1301 INN of investigational material : Therapeutic category code : 631 Vaccines Dosage and Administration for Investigational material : 0.5 mL, subcu

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy adults

Exclusion criteria

Exclusion criteria: History of diphtheria, tetanus, pertussis injection Individuals who received vaccines containing diphtheria, tetanus, or pertussis within 5 years

Design outcomes

Primary

Measure	Time frame
safety	—

Secondary

Measure	Time frame
immunogenicity	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026